气溶吸入向炎症细胞的树脂-甲松合剂,以有效的过敏喘治疗
Danfei Chen1, Xiaobo Xuan1, Yuyan Chen1
1Department of Pediatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Zhejiang Chinese Medical University, Hangzhou 310006, China.
一种新型的树脂-甲联体通过GGT受体识别准过敏性喘 (AA) 中的炎症细胞. 这种向的吸入疗法提供持续的药物释放和减少炎症,以有效的AA治疗.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 呼吸系统医学 呼吸系统医学
背景情况:
- 过敏性喘 (AA) 是一种普遍存在的呼吸系统疾病,以持续的炎症为标志.
- 目前的AA治疗缺乏足够的疗效和治疗多样性.
- 在AA肺组织中的炎症细胞上,马-氨基转移酶 (GGT) 过度表达.
研究的目的:
- 开发和评估一种特定于GGT的树脂-甲联合体 (GSHDDC) 用于向的AA疗法.
- 在过敏性喘的小鼠模型中评估气溶吸入GSHDDC的疗效.
主要方法:
- 通过甲与聚胺胺树脂体的共价附着来制造GSHDDC,并与谷氨功能化.
- 在卵胺诱导的AA小鼠中,通过气溶吸入施加GSHDDC.
- 通过GGT受体介导的细胞内和抗炎作用对细胞吸收的评估.
主要成果:
- GSHDDC有效地准了肺部GGT过度表达的炎症细胞.
- 快速阴性化介导的内细胞分裂促进了细胞内药物递送.
- 持续释放的德克萨米他导致了低色素透和炎症因素的减少.
- 在接受治疗的小鼠中观察到过敏性喘症状的显著减少.
结论:
- GSHDDC证明了对过敏性喘有效的向治疗和持续的抗炎作用.
- 这种向性合物的吸入给药为AA提供了有前途的治疗策略.
- GGT - 连接体/受体相互作用为肺部炎症细胞的积极向提供了一种新的机制.
更多相关视频
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Inhaled Medications
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
